GRANULES INDIA
|
The Current P/E Ratio of GRANULES INDIA is 23.84.
Share Price | ₹492.8 | Jul 04,2025 |
Market Cap | ₹11,955.3 Cr | |
Earnings-TTM | ₹501.5 Cr | TTM-Consolidated Results |
Price/Earnings | 23.84x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GRANULES INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹11,955.3 Cr] as on Jul 04,2025
(/) Earnings [ ₹501.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 23.84x ]
Thus, for GRANULES INDIA , the investors are currently willing to pay 23.84 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GRANULES INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GRANULES INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of GRANULES INDIA
PE Ratio Performance Analysis for GRANULES INDIA
- GRANULES INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 16.46x.
- GRANULES INDIA 's operated at median p/e ratio of 13.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GRANULES INDIA 's p/e ratio peaked in Mar2024 at 25.71x.
- GRANULES INDIA 's p/e ratio hit its five-year low in Mar2020 of 10.89x.
How does GRANULES INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GRANULES INDIA | 501.52 | 23.84 | 11,955.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.64 | 402,284.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 83.65 | 183,268.0 |
CIPLA LTD | 5,291.05 | 23.11 | 122,253.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 59.65 | 113,988.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.10 | 108,921.0 |
MANKIND PHARMA LTD | 2,003.22 | 50.26 | 100,677.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.83 | 100,724.0 |
LUPIN LTD | 3,306.26 | 27.31 | 90,285.9 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.67 | 69,150.2 |
ABBOTT INDIA LTD | 1,414.44 | 52.20 | 73,833.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GRANULES INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.10x |
Max industry PE | 83.65x |
Median industry PE | 27.31x |
Average industry PE | 37.93x |
You may also like the below Video Courses